Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 1
2017 1
2018 2
2020 2
2021 3
2022 8
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Author response.
Stoll F, Gödde M, Leo A, Katus HA, Müller OJ. Stoll F, et al. Clin Cardiol. 2018 Dec;41(12):1528. doi: 10.1002/clc.23084. Epub 2018 Oct 4. Clin Cardiol. 2018. PMID: 30259541 Free PMC article. No abstract available.
Drug-coated balloons in below-the-knee arteries.
Stoll F, Uslu R, Blessing E, Frey N, Katus HA, Erbel C, Heilmeier B, Müller OJ. Stoll F, et al. Vasa. 2022 Jul;51(4):256-262. doi: 10.1024/0301-1526/a001009. Epub 2022 May 23. Vasa. 2022. PMID: 35604329 Free article.
First-in-human, randomized, double-blind, placebo-controlled, dose escalation trial of the anti-herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers.
Blank A, Hohmann N, Dettmer M, Manka-Stuhlik A, Mikus G, Stoll F, Stützle-Schnetz M, Thomas D, Exner E, Schmitt-Bormann B, Schaller T, Laage R, Schönborn-Kellenberger O, Arndt M, Haefeli WE, Krauss J. Blank A, et al. Among authors: stoll f. Clin Transl Sci. 2022 Oct;15(10):2366-2377. doi: 10.1111/cts.13365. Epub 2022 Jul 23. Clin Transl Sci. 2022. PMID: 35869929 Free PMC article. Clinical Trial.
Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin.
Krohmer E, Rohr BS, Stoll F, Gümüs KS, Bergamino M, Mikus G, Sauter M, Burhenne J, Weiss J, Meid AD, Czock D, Blank A, Haefeli WE. Krohmer E, et al. Among authors: stoll f. Cardiovasc Drugs Ther. 2023 Dec 19. doi: 10.1007/s10557-023-07538-w. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 38112932
22 results